Article 25 Nov 2021 Biden Administration Issues Rules Requiring Insurer Transparency On Drug Spending, Rebates And Fees: What Manufacturers Need To Know United States Healthcare
Article 25 Nov 2020 Pharmacy Point-Of-Sale Price Concession And PBM Service Fee Safe Harbor Final Rule May Reshape Medicare Part D: What Pharmaceutical Manufacturers Need To Know Now United States Healthcare
Article 14 Nov 2020 Navigating The Post-Election Landscape: Life Sciences & Healthcare United States Healthcare
Article 29 Oct 2019 HHS Proposes New Protections For Value-Based Arrangements And Other Revisions To AKS Safe Harbors, CMP Exceptions And Stark Exceptions United States Healthcare
Article 11 Feb 2019 HHS OIG's Proposed Rule: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals United States Healthcare
Article 13 Nov 2018 Impact Of The Mid-Term Elections On The Life Sciences Industry United States Healthcare
Article 16 May 2018 Trump Administration Issues Blueprint To Lower Drug Prices And Reduce Out-Of-Pocket Costs United States Healthcare